TY - JOUR
T1 - CT of hepatocellular carcinoma in non-alcoholic fatty liver disease
T2 - imaging characteristics and interrater agreement
AU - Garg, Ishan
AU - Thompson, Scott M.
AU - Sheedy, Shannon P.
AU - Mounajjed, Taofic
AU - Khandelwal, Ashish
AU - Ehman, Eric C.
AU - Bookwalter, Candice A.
AU - Venkatesh, Sudhakar K.
N1 - Publisher Copyright:
© The Author(s) 2019.
PY - 2019
Y1 - 2019
N2 - Aim: To determine the computed tomography (CT) features of non-alcoholic fatty liver disease (NAFLD) associated hepatocellular carcinoma (HCC). Methods: In this institutional review board approved study, we reviewed 38 patients with NAFLD (68.4% male; mean age 63 years) with histology confirmed HCC and triphasic liver CT. CT images were independently reviewed by four readers blinded to clinical and pathology data. The reviewers assessed HCC for arterial phase hyper enhancement (APHE), portal venous phase washout (PVWO), delayed phase washout (DPWO), and enhancing capsule. Features of cirrhotic morphology and portal hypertension (PH) were also evaluated. The final CT features were determined by majority and a fifth reader reviewed cases lacking majority. Inter-rater agreement was determined by prevalenceadjusted kappa. Results: Mean HCC size was 3.6 ± 2.8 cm (range, 1.1-16.0 cm). The HCCs showed APHE in 92.1%, PVWO in 55.3%, DPWO in 81.6%, and enhancing capsule in 44.7%. Cirrhotic morphology was present in 65.8% and PH in 63.2%. Inter-rater agreement was moderate to almost perfect for APHE (0.74-1.0), cirrhosis (0.79-0.89), and PH (0.790.95), weak to perfect for DPWO (0.47-0.95) and poor for PVWO (0-0.42). Conclusion: NAFLD associated HCC demonstrate less frequent portal venous washout on CT which may affect their imaging diagnosis.
AB - Aim: To determine the computed tomography (CT) features of non-alcoholic fatty liver disease (NAFLD) associated hepatocellular carcinoma (HCC). Methods: In this institutional review board approved study, we reviewed 38 patients with NAFLD (68.4% male; mean age 63 years) with histology confirmed HCC and triphasic liver CT. CT images were independently reviewed by four readers blinded to clinical and pathology data. The reviewers assessed HCC for arterial phase hyper enhancement (APHE), portal venous phase washout (PVWO), delayed phase washout (DPWO), and enhancing capsule. Features of cirrhotic morphology and portal hypertension (PH) were also evaluated. The final CT features were determined by majority and a fifth reader reviewed cases lacking majority. Inter-rater agreement was determined by prevalenceadjusted kappa. Results: Mean HCC size was 3.6 ± 2.8 cm (range, 1.1-16.0 cm). The HCCs showed APHE in 92.1%, PVWO in 55.3%, DPWO in 81.6%, and enhancing capsule in 44.7%. Cirrhotic morphology was present in 65.8% and PH in 63.2%. Inter-rater agreement was moderate to almost perfect for APHE (0.74-1.0), cirrhosis (0.79-0.89), and PH (0.790.95), weak to perfect for DPWO (0.47-0.95) and poor for PVWO (0-0.42). Conclusion: NAFLD associated HCC demonstrate less frequent portal venous washout on CT which may affect their imaging diagnosis.
KW - Hepatocellular carcinoma
KW - computed tomography
KW - fatty liver
KW - inter-rater agreement
KW - non-alcoholic fatty liver disease
UR - http://www.scopus.com/inward/record.url?scp=85128859467&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128859467&partnerID=8YFLogxK
U2 - 10.20517/2394-5079.2019.009
DO - 10.20517/2394-5079.2019.009
M3 - Article
AN - SCOPUS:85128859467
SN - 2394-5079
VL - 5
JO - Hepatoma Research
JF - Hepatoma Research
M1 - 39
ER -